Cooper Laurence James Neil - Net Worth and Insider Trading
Cooper Laurence James Neil Net Worth
The estimated net worth of Cooper Laurence James Neil is at least $29,268 dollars as of 2024-11-13. Cooper Laurence James Neil is the President and CEO of Alaunos Therapeutics Inc and owns about 11,995 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $29,268. Details can be seen in Cooper Laurence James Neil's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cooper Laurence James Neil has not made any transactions after 2021-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cooper Laurence James Neil
Cooper Laurence James Neil Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cooper Laurence James Neil owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .
Click here to see the complete history of Cooper Laurence James Neil’s form 4 insider trades.
Insider Ownership Summary of Cooper Laurence James Neil
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TCRT | Alaunos Therapeutics Inc | 2021-01-04 | Chief Executive Officer |
Cooper Laurence James Neil Latest Holdings Summary
Cooper Laurence James Neil currently owns a total of 1 stock. Cooper Laurence James Neil owns 11,995 shares of Alaunos Therapeutics Inc (TCRT) as of January 4, 2021, with a value of $29,268.
Latest Holdings of Cooper Laurence James Neil
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TCRT | Alaunos Therapeutics Inc | 2021-01-04 | 11,995 | 2.44 | 29,268 |
Holding Weightings of Cooper Laurence James Neil
Cooper Laurence James Neil Form 4 Trading Tracker
According to the SEC Form 4 filings, Cooper Laurence James Neil has made a total of 2 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Alaunos Therapeutics Inc is the sale of 705 shares on January 4, 2021, which brought Cooper Laurence James Neil around $286,428.
Insider Trading History of Cooper Laurence James Neil
- 1
Cooper Laurence James Neil Trading Performance
GuruFocus tracks the stock performance after each of Cooper Laurence James Neil's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cooper Laurence James Neil is -18.22%. GuruFocus also compares Cooper Laurence James Neil's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cooper Laurence James Neil within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cooper Laurence James Neil's insider trading performs compared to the benchmark.
Performance of Cooper Laurence James Neil
Cooper Laurence James Neil Ownership Network
Ownership Network List of Cooper Laurence James Neil
Ownership Network Relation of Cooper Laurence James Neil
Cooper Laurence James Neil Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
Cooper Laurence James Neil is the Chief Executive Officer of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, Cooper Laurence James Neil made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
Cooper Laurence James Neil Mailing Address
Above is the net worth, insider trading, and ownership report for Cooper Laurence James Neil. You might contact Cooper Laurence James Neil via mailing address: C/o Ziopharm Oncology, Inc., 1 First Ave, Parris Building #34, Boston Ma 02129.